JAK inhibitors and COVID-19.
Journal article
Levy G. et al, (2022), Journal for immunotherapy of cancer, 10
Human genetic and immunological determinants of critical COVID-19 pneumonia
Journal article
Zhang Q. et al, (2022), Nature
Degrading JAK2 in ALL by ruxolitinib-based PROTACs
Journal article
Constantinescu SN. and Pecquet C., (2021), Blood, 138, 2301 - 2302
MPL S505C enhances driver mutations at W515 in essential thrombocythemia.
Journal article
Varghese LN. et al, (2021), Blood cancer journal, 11
Pituitary incidentaloma.
Journal article
Constantinescu SM. and Maiter D., (2021), Presse medicale (Paris, France : 1983)
Inferring the dynamic of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms.
Journal article
Mosca M. et al, (2021), Blood
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Journal article
Bastard P. et al, (2021), Science immunology, 6
CALR mutant protein rescues the response of MPL p.R464G variant associated with CAMT to eltrombopag.
Journal article
Basso-Valentina F. et al, (2021), Blood
Functional Consequences of Mutations in Myeloproliferative Neoplasms
Journal article
Constantinescu SN. et al, (2021), HemaSphere
Targets in MPNs and potential therapeutics
Chapter
Levy G. et al, (2021), International Review of Cell and Molecular Biology